Influence of oral glutamine supplementation on survival outcomes of patients treated with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer

被引：0
|
作者：
Erkan Topkan
Cem Parlak
Savas Topuk
Berrin Pehlivan
机构：
[1] Baskent University Adana Medical Faculty,Department of Radiation Oncology
[2] Memorial Health Group,Department of Radiation Oncology
[3] Medstar Antalya Hospital,undefined
来源：
BMC Cancer | / 12卷
关键词：
Concurrent chemotherapy; Radiotherapy; Glutamine supplementation; Lung cancer; Survival outcome; Tumor growth;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Influence of oral glutamine supplementation on survival outcomes of patients treated with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer
    Topkan, Erkan
    Parlak, Cem
    Topuk, Savas
    Pehlivan, Berrin
    [J]. BMC CANCER, 2012, 12
  • [2] ORAL GLUTAMINE SUPPLEMENTATION HAS NO NEGATIVE IMPACT ON SURVIVAL IN LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER TREATED WITH CONCURRENT CHEMORADIOTHERAPY
    Topkan, E.
    Yuksel, O.
    Kotek, A.
    Parlak, C.
    Pehlivan, B.
    [J]. LUNG CANCER, 2011, 71 : S43 - S43
  • [3] WEIGHT LOSS DESPITE ORAL GLUTAMINE SUPPLEMENTATION PREDICTS POOR PROGNOSIS IN LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH CONCURRENT CHEMORADIOTHERAPY
    Parlak, C.
    Topuk, S.
    Ozyilkan, O.
    Topkan, E.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 520 - 521
  • [4] The effects of oral glutamine on clinical and survival outcomes of non-small cell lung cancer patients treated with chemoradiotherapy
    Gul, Kanyilmaz
    Mehmet, Koc
    Meryem, Aktan
    [J]. CLINICAL NUTRITION, 2017, 36 (04) : 1022 - 1028
  • [5] Daily Step Counts Predict Outcomes for Locally Advanced Non-Small Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy
    Ohri, N.
    Halmos, B.
    Bodner, W. R., III
    Cheng, H.
    Guha, C.
    Kalnicki, S.
    Garg, M. K.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E524 - E525
  • [6] Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy
    Bergamino, Milana
    Rullan, Antonio J.
    Saigi, Maria
    Peiro, Inmaculada
    Montanya, Eduard
    Palmero, Ramon
    Carlos Ruffinelli, Jose
    Navarro, Arturo
    Dolores Arnaiz, Maria
    Brao, Isabel
    Aso, Samantha
    Padrones, Susana
    Cardenal, Felipe
    Nadal, Ernest
    [J]. BMC CANCER, 2019, 19 (1)
  • [7] Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy
    Milana Bergamino
    Antonio J. Rullan
    Maria Saigí
    Inmaculada Peiró
    Eduard Montanya
    Ramón Palmero
    José Carlos Ruffinelli
    Arturo Navarro
    María Dolores Arnaiz
    Isabel Brao
    Samantha Aso
    Susana Padrones
    Felipe Cardenal
    Ernest Nadal
    [J]. BMC Cancer, 19
  • [8] IMPACT OF PRETRETMENT LEUKOCYTOSIS ON PROGNOSIS IN LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH CONCURRENT CHEMORADIOTHERAPY
    Topkan, Erkan
    Parlak, Cem
    Pehlivan, Berrin
    Ozyilkan, Ozgur
    Selek, Ugur
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S556 - S556
  • [9] IMPACT OF PRETRETMENT LEUKOCYTOSIS ON PROGNOSIS IN LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH CONCURRENT CHEMORADIOTHERAPY
    Topkan, Erkan
    Parlak, Cem
    Guler, Ozan C.
    Pehlivan, Berrin
    Selek, Ugur
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S412 - S412
  • [10] Modeling Survival Outcomes of Immune Checkpoint Inhibitors on Locally Advanced Non-Small Cell Lung Cancer Following Concurrent Chemoradiotherapy
    Huang, H. T.
    Hawkins, M. A.
    Fenwick, J. D.
    Nix, M. G.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E375 - E375
12345